Filed pursuant to Rule 433
Issuer Free Writing Prospectus dated August 28, 2020
Relating to Preliminary Prospectus Supplement dated August 27, 2020
to Prospectus dated June 9, 2020
Registration No. 333-239047

NIO Inc., or the Company, we or us, has filed a registration statement on Form F-3 (Registration No. 333-239047), including a prospectus dated June 9, 2020, and a preliminary prospectus supplement dated August 27, 2020 with the Securities and Exchange Commission (the “SEC”) for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus included in the registration statement, the preliminary prospectus supplement, the documents incorporated by reference in the registration statement and other documents the Company has filed with the SEC for more complete information about us and this offering. Investors should rely upon the prospectus, the preliminary prospectus supplement and any relevant free writing prospectus for complete details of this offering. You may obtain these documents and other documents the Company has filed for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement, if you request them by contacting (1) Morgan Stanley & Co. LLC, Prospectus Department, 2nd Floor, 180 Varick Street, New York, NY 10014, United States of America, Attention: Prospectus Department; (2) China International Capital Corporation Hong Kong Securities Limited, 29th Floor, One International Finance Centre, 1 Harbour View Street, Central, Hong Kong; or (3) BofA Securities, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attention: Prospectus Department, Email: dg.prospectus_requests@bofa.com. You may also access the Company’s most recent preliminary prospectus supplement dated August 27, 2020, as filed with the SEC via EDGAR on August 27, 2020, by visiting EDGAR on the SEC website at: https://www.sec.gov/Archives/edgar/data/1736541/000110465920099693/tm2022004-6_424b5.htm.

The following information supplements and updates the information contained in the Company’s preliminary prospectus supplement dated August 27, 2020 (the “Preliminary Prospectus Supplement”). In the Preliminary Prospectus Supplement, we proposed to offer 75,000,000 ADSs and grant the underwriters an option to purchase up to an aggregate of 11,250,000 additional ADSs from us. The number of ADSs to be offered by us in the offering has increased to 88,500,000 ADSs, and we will grant the underwriters an option to purchase up to an aggregate of 13,275,000 additional ADSs from us.

This issuer free writing prospectus updates certain information contained in the Preliminary Prospectus Supplement to reflect the increases in the number of ADSs being offered, the impact on net proceeds and capitalization, as well as certain other changes. This free writing prospectus reflects the following amendments and supplements that were made to the Preliminary Prospectus Supplement. All references to page numbers are to page numbers in the Preliminary Prospectus Supplement.

THE OFFERING

We estimate that the net proceeds to us from this offering will be approximately US$1,469.5 million (or approximately US$1,690.1 million assuming the underwriters exercise their option to purchase additional ADSs in full), after deducting underwriting commissions and fees and the estimated offering expenses payable by us.

CAPITALIZATION

The following table sets forth our capitalization as of June 30, 2020:

The pro forma as adjusted information is illustrative only. You should read this table in conjunction with our consolidated financial statements and related notes included and “Item 5. Operating and Financial Review and Prospects” in our 2019 Annual Report, which is incorporated by reference in this prospectus supplement and the accompanying prospectus.